Pliant Therapeutics, Inc.
PLRXBiotechnology
$0.86−0.13%As of Oct 30vs prior close
- Market cap
- $53.2M
- P/E (TTM)
- –
- From 52W high
- −52.28%
- EPS (YE25)
- -$2.43
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
14
Steady ProfileBottom 4% of the scored universe
Growth44
Quality29
Value31
Momentum6
Resilience40
Growth
$0revenue, YE25
YE19 $57.1MYE25 $0
Connections
Revenue to profitQ2 YE23
The operating loss was 19084% of revenue, wider by 18490 pts on a year.
Who owns it
1fund